As the 2-year anniversary of the overturning of Roe v. Wade approaches, abortion and bodily autonomy remain at the forefront of national conversation. Today, the Senate will vote on the Right to ...

Illustration by the Atlantic. Source: SSPL / Getty. “From the get-go, the researchers involved in developing male contraception have paid extra- close attention to: Can we develop products for which ...

This line of argument could resonate with other conservative groups in the European Parliament opposed to abortion ...

Contraception has always been a divisive topic. After the Supreme Court overturned Roe v. Wade in 2022, a number of U.S. states set abortion restrictions — making access to birth control even more ...

Contraline, a biotech company, has received regulatory approval to move onto Phase 2 of human clinical trials for a male contraceptive that conveniently blocks sperm for up to two years. Contraline ...

A hormone-free male contraceptive pill called YCT-529 has successfully completed its first human safety trial, marking an ...

A hormone-free male birth control pill is undergoing clinical testing for the first time ever. The drug, called YCT-529, has performed incredibly well at limiting the production of sperm in mice and ...

Photo composite of human egg (oocyte) and sperm (spermatozoon), colored scanning electron micrograph (SEM). In the first clinical trial of its kind, a nonhormonal oral contraceptive that reversibly ...

A drug with a past life as a potential anti-cancer agent might someday have a new job as "the pill" for men, new data in mice suggest. In a journal article published Feb. 20 in Proceedings of the ...

Just a few years ago, the new male contraceptive seemed like an inevitable reality. Major pharmaceutical companies like Wyeth, Schering and Organon were pumping millions into hormonal birth-control ...